Wealth Enhancement Advisory Services Portfolio holdings
AUM
$60.4B
1-Year Return
15.61%
This Quarter Return
-0.8%
1 Year Return
+15.61%
3 Year Return
+48.2%
5 Year Return
+69.03%
10 Year Return
+118.46%
AUM
$52.3B
AUM Growth
+$75.9M
(+0.15%)
Cap. Flow
+$1.19B
Cap. Flow
% of AUM
2.28%
Top 10 Holdings %
Top 10 Hldgs %
23.14%
Holding
3,156
New
280
Increased
1,557
Reduced
1,033
Closed
222
Top Buys
| 1 |
VictoryShares US Small Mid Cap Value Momentum ETF
USVM
|
+$526M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$314M |
| 3 |
SPDR Portfolio S&P 500 Value ETF
SPYV
|
+$114M |
| 4 |
Avantis US Large Cap Value ETF
AVLV
|
+$113M |
| 5 |
Palantir
PLTR
|
+$92.5M |
Top Sells
| 1 |
SPDR S&P 400 Mid Cap Value ETF
MDYV
|
+$333M |
| 2 |
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
|
+$175M |
| 3 |
Amazon
AMZN
|
+$149M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$123M |
| 5 |
Invesco NASDAQ 100 ETF
QQQM
|
+$97.5M |
Sector Composition
| 1 | Technology | 11.34% |
| 2 | Financials | 6.64% |
| 3 | Healthcare | 4.39% |
| 4 | Industrials | 4.34% |
| 5 | Consumer Discretionary | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2851
E.W. Scripps
SSP
$259M
| $30.6K | ﹤0.01% |
10,340
-6,395
| -38% | -$18.9K |
|
2852
Blink Charging
BLNK
$130M
| $30.4K | ﹤0.01% |
+33,138
| New | +$30.4K |
|
|
OGI
2853
Organigram Holdings
OGI
$220M
| $30.4K | ﹤0.01% |
+30,082
| New | +$30.4K |
|
|
GPMT
2854
Granite Point Mortgage Trust
GPMT
$141M
| $30.3K | ﹤0.01% |
+11,655
| New | +$30.3K |
|
2855
Oramed Pharmaceuticals
ORMP
$93.5M
| $29.5K | ﹤0.01% |
13,799
| – | – |
|
2856
Ventyx Biosciences
VTYX
$178M
| $28.2K | ﹤0.01% |
+24,483
| New | +$28.2K |
|
2857
Allogene Therapeutics
ALLO
$244M
| $28.1K | ﹤0.01% |
+19,260
| New | +$28.1K |
|
|
MIN
2858
MFS Intermediate Income Trust
MIN
$310M
| $27.5K | ﹤0.01% |
10,235
-7,040
| -41% | -$18.9K |
|
2859
Leslie's
LESL
$62M
| $27.4K | ﹤0.01% |
37,279
+19,257
| +107% | +$14.2K |
|
2860
Destination XL Group
DXLG
$68.4M
| $27K | ﹤0.01% |
18,460
+392
| +2% | +$572 |
|
2861
Coherus Oncology, Inc. Common Stock
CHRS
$156M
| $26.8K | ﹤0.01% |
33,249
+2,402
| +8% | +$1.94K |
|
|
EQC
2862
DELISTED
Equity Commonwealth
EQC
| $26.5K | ﹤0.01% |
+16,432
| New | +$26.5K |
|
2863
NanoViricides
NNVC
$23.1M
| $25.9K | ﹤0.01% |
+22,138
| New | +$25.9K |
|
2864
Rafael Holdings
RFL
$48.8M
| $25.6K | ﹤0.01% |
+13,887
| New | +$25.6K |
|
2865
ALX Oncology
ALXO
$58.4M
| $25.3K | ﹤0.01% |
40,551
+1,420
| +4% | +$885 |
|
2866
Clear Channel Outdoor Holdings
CCO
$706M
| $24.9K | ﹤0.01% |
22,446
-10,990
| -33% | -$12.2K |
|
2867
Stem
STEM
$116M
| $24.4K | ﹤0.01% |
+3,481
| New | +$24.4K |
|
2868
Prime Medicine
PRME
$683M
| $24.3K | ﹤0.01% |
+12,230
| New | +$24.3K |
|
2869
3D Systems Corporation
DDD
$276M
| $24.3K | ﹤0.01% |
+11,461
| New | +$24.3K |
|
2870
Pacific Biosciences
PACB
$375M
| $24K | ﹤0.01% |
20,374
-2,599
| -11% | -$3.07K |
|
2871
Fate Therapeutics
FATE
$109M
| $23.6K | ﹤0.01% |
+29,909
| New | +$23.6K |
|
2872
MAIA Biotechnology
MAIA
$51.5M
| $22.6K | ﹤0.01% |
14,800
| – | – |
|
2873
Standard BioTools
LAB
$497M
| $21.9K | ﹤0.01% |
+20,250
| New | +$21.9K |
|
2874
GrafTech
EAF
$223M
| $21.4K | ﹤0.01% |
+2,447
| New | +$21.4K |
|
2875
Cibus
CBUS
$68.3M
| $21.2K | ﹤0.01% |
+11,314
| New | +$21.2K |
|